Vimarsana
Biggest News Aggregation in the World

Relapsing Forms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relapsing Forms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relapsing Forms Today - Breaking & Trending Today

Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis - Vimarsana News

Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis

Published: August 25, 2023

Polpharma Biologics Announces FDA Approval of Tyruko® -  First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple SclerosisAMSTERDAM, The Netherlands, August 25, 2023 / B3C newswire / -- Polpharma Biologics, an international biotech company dedicated to the development and ma...

Source: pharmiweb.com
Related Topics:
Noord HollandMichael SoldanPolpharma BiologicsEuropean Medicines AgencyPolpharma Biologics GroupDrug AdministrationPolpharma Biologics AnnouncesFirst And Only Approved BiosimilarRelapsing FormsChief Executive OfficerRisk EvaluationMitigation Strategy
Viatris and Mapi Pharma to Highlight Latest Results of Multiple Sclerosis Research at American Academy of Neurology 75th Annual Meeting - Vimarsana News

Viatris and Mapi Pharma to Highlight Latest Results of Multiple Sclerosis Research at American Academy of Neurology 75th Annual Meeting

Published: April 24, 2023

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Mapi Pharma today announced that recent data from ongoing studies of GA Depot 40...

Source: prnewswire.com
Related Topics:
United StatesAndhra PradeshAarone MillerAbhijit BarveMapi PharmaFingolimod GilenyaApremilast OtezlaEhud MaromViatris IncExhibition CenterBoston ConventionPrnewswire Viatris IncAmerican Academy Of NeurologyAmerican AcademyAnnual MeetingChief Medical OfficerChief Executive OfficerPlacebo Controlled StudyRelapsing FormsMultiple SclerosisGlatiramer AcetateAdministered Once Every FourGlobal HealthcareFinished Dosage FormsViatris Inc
Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS - Vimarsana News

Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS

Published: March 13, 2023

/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral medications. The drug is...

Source: prnewswire.com
Related Topics:
North CarolinaUnited StatesSanofi Genzyme AubagioJim BrownAccord Healthcare IncIntas PharmaceuticalsFood Drug AdministrationSanofi GenzymeSales JimSafety InformationAccord HealthcareRelapsing FormsPrescribing InformationAccord Healthcare Us
ACTRIMS 2023: GA Depot reduces MS relapses in Phase 3 trial | Long-acting glatiramer acetate also helps ease patients' disability - Vimarsana News

ACTRIMS 2023: GA Depot reduces MS relapses in Phase 3 trial | Long-acting glatiramer acetate also helps ease patients' disability

Published: March 7, 2023

The long-acting glatiramer acetate therapy GA Depot was found to ease disability in patients with relapsing forms of MS in a Phase 3 trial.

Source: multiplesclerosisnewstoday.com
Related Topics:
New YorkUnited StatesSan DiegoAaron MillerMapi PharmaIcahn School Of Medicine At Mount SinaiAmericas Committee For TreatmentDrug AdministrationResearch In Multiple SclerosisIcahn School Of MedicineCorinne Goldsmith Dickinson CenterAmericas CommitteeMultiple SclerosisIcahn SchoolMount SinaiDouble BlindPlacebo Controlled StudyRelapsing FormsGlatiramer AcetateAdministered Once Every Four WeeksExpanded Disability Status Scale
Mapi Pharma to Host a Key Opinion Leader Webinar on - Vimarsana News

Mapi Pharma to Host a Key Opinion Leader Webinar on

Published: October 12, 2022

GA Depot is a Potential Long Acting Injection Solution for Multiple Sclerosis Patients Positive Results from Phase III GA Depot Study in Relapsing MS to...

Source: globenewswire.com
Related Topics:
New YorkUnited StatesIsrael GeneralEhud MaromCarlo TornatoreFingolimod GilenyaAaron MillerAlex MogleApremilast OtezlaBob YedidMapi PharmaLaboratory Of Molecular MedicineNational Institute For Neurologic DisordersDepartment Of NeurologyDivision Of Neurology At Maimonides Medical CenterGeorgetown University Medical CenterNational BoardNeurology At Medstar HealthMapi Pharma LtdPhysiology At Georgetown UniversityCorinne Dickinson CenterGeorgetown University HospitalGems CentersGeorgetown University Medical SchoolSclerosis Care Center